CEO of Optinose Inc (OPTN, Financial) Peter K Miller bought 10,752 shares of OPTN on 08/15/2018 at an average price of $14.32 a share. The total cost of this purchase was $153,969.
OptiNose Inc is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. OptiNose Inc has a market cap of $540.810 million; its shares were traded at around $13.26 with and P/S ratio of 576.55.
CEO Recent Trades:
- CEO Peter K Miller bought 10,752 shares of OPTN stock on 08/15/2018 at the average price of $14.32. The price of the stock has decreased by 7.4% since.
Directors and Officers Recent Trades:
- Chief Commercial Officer Thomas Edward Gibbs bought 2,000 shares of OPTN stock on 08/15/2018 at the average price of $12.69. The price of the stock has increased by 4.49% since.
For the complete insider trading history of OPTN, click here
.
